Literature DB >> 16530129

Endothelial dysfunction in type 2 diabetes mellitus.

Angelo Avogaro1, Gian Paolo Fadini, Alessandra Gallo, Elisa Pagnin, Saula de Kreutzenberg.   

Abstract

AIMS: Vascular endothelial cells play a major role in maintaining cardiovascular homeostasis in health. Diabetes mellitus (DM) substantially impairs the vasodilating properties of the endothelium and leads to endothelial dysfunction, which can thus be considered the first step in the progression of cardiovascular disease. The aim of the present study is to illustrate possible mechanisms responsible for endothelial dysfunction in DM. DATA SYNTHESIS: We have shown that NADPH oxidase gene expression is increased in circulating lymphomonocytes from patients with DM, and that this increased gene expression is dependent upon metabolic control. Hyperglycemia can mediate its adverse effects through the activation of protein kinase C. We have shown an increase in membrane-associated PKC beta 2 activity in monocytes from patients with DM. This activity was reduced by 40% in the euglycemic condition. Finally, we show a reduction of the circulating endothelial progenitor cells, a subset of bone marrow-derived endothelial-oriented stem cells, which can give rise to mature endothelial cells.
CONCLUSION: Endothelial dysfunction, the initial step of the atherosclerotic process, is reversible. Thus, major efforts should be made to control not only hyperglycemia but also the other risk factors for cardiovascular disease, in order to prevent the onset of all these processes that eventually leads the diabetic patient to premature death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530129     DOI: 10.1016/j.numecd.2005.10.015

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  36 in total

1.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 2.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

3.  Combining laser-Doppler flowmetry measurements with spectral analysis to study different microcirculatory effects in human prediabetic and diabetic subjects.

Authors:  Hsiao-Feng Hu; Hsin Hsiu; Ciao-Jyuan Sung; Chien-Hsing Lee
Journal:  Lasers Med Sci       Date:  2016-12-07       Impact factor: 3.161

4.  Marrow-isolated adult multilineage inducible cells embedded within a biologically-inspired construct promote recovery in a mouse model of peripheral vascular disease.

Authors:  Cristina Grau-Monge; Gaëtan J-R Delcroix; Andrea Bonnin-Marquez; Mike Valdes; Ead Lewis Mazen Awadallah; Daniel F Quevedo; Maxime R Armour; Ramon B Montero; Paul C Schiller; Fotios M Andreopoulos; Gianluca D'Ippolito
Journal:  Biomed Mater       Date:  2017-02-17       Impact factor: 3.715

Review 5.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

6.  Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.

Authors:  Soo-Kyoung Choi; Maria Galán; Modar Kassan; Megan Partyka; Mohamed Trebak; Khalid Matrougui
Journal:  Hypertension       Date:  2012-03-26       Impact factor: 10.190

7.  Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol.

Authors:  Emile R Mohler; Yuquan Shi; Jonni Moore; Andrew Bantly; Damir Hamamdzic; Mervin Yoder; Daniel J Rader; Mary Putt; Lifeng Zhang; Michael Parmacek; Robert L Wilensky
Journal:  Cytometry A       Date:  2009-01       Impact factor: 4.355

8.  Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Saula de Kreutzenberg; Carlo Agostini; Florian Seeger; Stefanie Dimmeler; Andreas Zeiher; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

9.  Relationship of ghrelin, acid uric and proinflammatory adipocytokines in different degrees of obesity or diabetes.

Authors:  María Pilar Cruz-Domínguez; Daniel H Montes Cortés; Arturo Zarate; María de Los Ángeles Tapia-González; Sandra Alvarez-Acosta; Leticia Damasio; Leticia Manuel-Apolinar
Journal:  Int J Clin Exp Med       Date:  2014-05-15

10.  Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice.

Authors:  Jun Su; Pamela A Lucchesi; Romer A Gonzalez-Villalobos; Desiree I Palen; Bashir M Rezk; Yasuhiro Suzuki; Hamid A Boulares; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-15       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.